title: Sore throat presentation and management in general practice.
abstract: OBJECTIVE
  To compare the characteristics of sore throat patients with their having normal throat, to measure the incidence of beta-haemolytic streptococcal growth in both groups, and to determine the clinical outcomes of treating sore throat patients without the aid of a throat swab.
  
  
  METHODS
  Patients were from a suburban general practice. A three phased prospective study of consecutive patients with sore throats as their primary complaint, or with normal throats.
  
  
  RESULTS
  Patients presented with a sore throat at a rate of 45 per 1000 consultations and those with normal throats presented at a rate of 379 per 1000 consultations. 43% of normal throat patients were male compared to 34% with sore throat (chi 2 = 4.62, p < 0.02). The incidence of beta-haemolytic streptococcal growth in sore throat patients was 123 per 1000 consultations per year. 23% of people 14 years and younger had a positive growth compared to 9% of people over 14 years of age. (chi 2 = 5.04, df = 1, p < 0.05). The sore throat presentation peaked over the late autumn to early winter months (June-July) but the beta-haemolytic streptococcal infection rate remained low throughout the year. A history of pain for less than three days and fever, and on examination large neck glands and pus on the tonsils were all positive clinical features for beta-haemolytic streptococcal infection. However use of clinical criteria alone meant 73% of patients with no beta-haemolytic streptococcal infection were falsely treated.
  
  
  CONCLUSIONS
  Research is needed to develop guidelines for the management of sore throats in general practice.
authors.affiliation: Wellington School of Medicine.
authors.forename: M
authors.initials: M
authors.lastname: Kljakovic
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001431:Bacteriological Techniques; D002648:Child; D005194:Family Practice; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009520:New Zealand / Q000453:epidemiology; D010406:Penicillins / Q000627:therapeutic use; D010612:Pharyngitis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D010614:Pharynx / Q000382:microbiology; D012621:Seasons; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D013291:Streptococcus / Q000302:isolation & purification; D016896:Treatment Outcome
chemical_list: D010406:Penicillins